Viewing

Latest News



CVI in children is still grossly underdiagnosed
0:50
CVI in children is still grossly underdiagnosed
4 days ago
AI in retina: A new collaborator in the fight against blindness
1:10
AI in retina: A new collaborator in the fight against blindness
5 days ago
Amy Zhang, MD: why surgeons should take 30 extra seconds before surgery | Amy Zhang, MD | © Amy Zhang, MD
0:59
Amy Zhang, MD: why surgeons should take 30 extra seconds before surgery
11 days ago
Honing in on early neurodegenerative disease via the IPL
0:46
Honing in on early neurodegenerative disease via the IPL
17 days ago
How AI is transforming retina care, from RPE analysis to predictive modeling
1:12
How AI is transforming retina care, from RPE analysis to predictive modeling
21 days ago
How AI can help shape future clinical trials
0:53
How AI can help shape future clinical trials
a month ago
Should patients use AI to research symptoms?
0:54
Should patients use AI to research symptoms?
a month ago
Why every eye doctor should check dry eye first
1:16
Why every eye doctor should check dry eye first
2 months ago
Treatment durability and Medicare status both drive retinal outcomes
0:38
Treatment durability and Medicare status both drive retinal outcomes
2 months ago
Ensuring cataract patients are happy
0:36
Redefining surgical success as "20/happy"
2 months ago

Digital Edition

(Image credit: AdobeStock/PaulStd) Visiting the doctor in a foreign land
Ophthalmology Times
Learning Brazilian Portuguese boosts brain resilience and may delay dementia symptoms, but a humorous lesson highlights the realities of health care paperwork and waiting rooms.
Q&A with Sunil S. Patel, MD, PhD | Ophthalmology Times
Ophthalmology Times
Sunil S. Patel, MD, PhD, of the University of Texas Southwestern Medical Center, breaks down QA102's first-in-class mechanism targeting harmful gut bacteria and retinal inflammation, what the phase 2 drusen volume and GA growth rate data reveal about the therapy's potential, and what a phase 3 program must address to bring an oral AMD treatment to patients without options.

Podcasts



All News

Two optical treatment modalities can slow pediatric myopia progression without the need for pharmacologic intervention, ie, spectacle lenses incorporating highly aspherical lenslets (HAL) and orthokeratology (ortho-k) contact lenses. Both treatments are based on the same underlying theory that peripheral retinal defocus is a growth signal for axial elongation‚ but the treatments focus on different structures of the visual system, one through a manufactured spectacle lens surface (HAL) and the other through temporary corneal reshaping (ortho-k).